Inbilt-F Solution is a topical formulation containing Minoxidil 5% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult patients. Minoxidil, a potent vasodilator, promotes hair follicle stimulation and prolongs the anagen phase of the hair growth cycle, thereby facilitating increased hair density and thickness. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combined action of Minoxidil and Finasteride in Inbilt-F Solution addresses both the symptomatic hair thinning and the underlying hormonal cause of androgenetic alopecia, offering a comprehensive therapeutic approach. This solution is intended for topical application to the affected scalp areas once daily, ensuring localized efficacy while minimizing systemic exposure. Clinical studies have demonstrated that the combination therapy significantly improves hair regrowth rates compared to monotherapy with either agent alone. Patients should adhere to the recommended dosage and avoid contact with eyes and mucous membranes. Use during pregnancy or lactation is contraindicated. Common adverse effects may include scalp irritation, itching, or erythema. Consultation with a healthcare professional is advised prior to initiation of treatment to ensure suitability and monitor for potential side effects.